Oliver Kepp Selected Research

Carcinogens

1/2021	A TLR3 Ligand Reestablishes Chemotherapeutic Responses in the Context of FPR1 Deficiency.
1/2019	Crizotinib-induced immunogenic cell death in non-small cell lung cancer.
1/2019	Anticancer effects of anti-CD47 immunotherapy in vivo.
12/2015	Morphometric analysis of immunoselection against hyperploid cancer cells.
9/2012	An immunosurveillance mechanism controls cancer cell ploidy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Oliver Kepp Research Topics

Disease

127	Neoplasms (Cancer) 10/2022 - 04/2003
13	Necrosis 01/2019 - 04/2009
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 03/2010
6	Lung Neoplasms (Lung Cancer) 01/2022 - 08/2012
6	Carcinoma (Carcinomatosis) 02/2014 - 06/2012
5	Carcinogenesis 01/2022 - 03/2012
5	Infections 12/2021 - 03/2009
4	Residual Neoplasm 01/2021 - 06/2010
4	Breast Neoplasms (Breast Cancer) 01/2019 - 05/2012
4	Fibrosarcoma 01/2019 - 06/2013
4	Tetraploidy 02/2014 - 04/2009
3	Colonic Neoplasms (Colon Cancer) 01/2022 - 02/2014
3	Melanoma (Melanoma, Malignant) 01/2022 - 01/2018
3	Colorectal Neoplasms (Colorectal Cancer) 10/2021 - 05/2012
3	Lymphoma (Lymphomas) 10/2021 - 01/2019
3	Osteosarcoma (Osteogenic Sarcoma) 01/2021 - 01/2013
3	Neoplasm Metastasis (Metastasis) 01/2020 - 11/2015
2	COVID-19 12/2021 - 01/2020
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021 - 01/2020
2	Cystic Fibrosis (Mucoviscidosis) 11/2019 - 01/2018
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2016 - 09/2013
2	Polyploidy 02/2014 - 06/2012
2	Inflammation (Inflammations) 09/2013 - 03/2012
2	Cadaver (Cadavers) 10/2010 - 06/2010

Drug/Important Bio-Agent (IBA)

19	Adenosine Triphosphate (ATP)IBA 01/2022 - 10/2009
18	AntigensIBA 01/2022 - 10/2008
18	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2008
18	CalreticulinIBA 01/2022 - 02/2009
16	AnthracyclinesIBA 01/2021 - 10/2008
13	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 06/2012
11	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 03/2010
10	HMGB1 Protein (HMG1)IBA 01/2022 - 10/2008
9	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 06/2010
8	Phosphotransferases (Kinase)IBA 01/2021 - 10/2009
6	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2017
6	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 04/2009
6	VaccinesIBA 01/2020 - 03/2012
5	CarcinogensIBA 01/2021 - 09/2012
5	CrizotinibIBA 01/2021 - 01/2019
5	Peptides (Polypeptides)IBA 01/2020 - 01/2015
5	Biomarkers (Surrogate Marker)IBA 01/2020 - 03/2014
4	Messenger RNA (mRNA)IBA 01/2022 - 01/2017
4	Histones (Histone)IBA 01/2021 - 04/2009
4	Pattern Recognition ReceptorsIBA 01/2021 - 02/2010
4	Neoplasm Antigens (Tumor Antigens)IBA 01/2020 - 03/2011
4	Pharmaceutical PreparationsIBA 01/2020 - 06/2010
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 06/2013
3	InterferonsIBA 01/2022 - 03/2014
3	AntibodiesIBA 01/2022 - 01/2019
3	LigandsIBA 01/2021 - 10/2010
3	ChromatinIBA 12/2019 - 01/2013
3	InflammasomesIBA 11/2017 - 03/2012
3	Digoxin (Digitek)FDA LinkGeneric 02/2013 - 07/2012
3	Small Interfering RNA (siRNA)IBA 07/2010 - 03/2009
2	Fatty Acids (Saturated Fatty Acids)IBA 10/2022 - 04/2015
2	Interferon Type IIBA 01/2022 - 11/2014
2	CytokinesIBA 01/2022 - 03/2014
2	Local AnestheticsIBA 01/2022 - 01/2021
2	Immunoconjugates (Immunoconjugate)IBA 01/2022 - 10/2021
2	Activating Transcription Factor 6IBA 01/2022 - 01/2018
2	Coenzyme A (CoA)IBA 01/2022 - 01/2019
2	X-Box Binding Protein 1IBA 01/2022 - 01/2018
2	Activating Transcription Factor 4IBA 01/2022 - 01/2018
2	RNA (Ribonucleic Acid)IBA 12/2021 - 01/2019
2	Immunoglobulin G (IgG)IBA 12/2021 - 06/2013
2	Annexin A1IBA 01/2021 - 01/2019
2	Oleic Acid (Oleate)IBA 01/2021 - 04/2015
2	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 01/2021 - 11/2015
2	Green Fluorescent ProteinsIBA 01/2021 - 01/2013
2	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2020 - 06/2013
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 01/2020
2	Recombinant ProteinsIBA 01/2020 - 06/2013
2	PM 01183IBA 01/2020 - 01/2019
2	Adenosine (Adenocard)FDA LinkGeneric 11/2017 - 03/2014
2	NucleotidesIBA 11/2017 - 10/2009
2	Serine-Threonine Kinase 3IBA 01/2017 - 06/2016
2	Caspase 3 (Caspase-3)IBA 06/2016 - 03/2012
2	Cytostatic AgentsIBA 12/2015 - 03/2011
2	Therapeutic UsesIBA 11/2015 - 06/2010
2	LTX-315IBA 09/2015 - 01/2015
2	Purinergic Receptors (Receptors, Purine)IBA 04/2013 - 05/2012
2	Cardiac GlycosidesIBA 02/2013 - 12/2012
2	pyrazolanthroneIBA 01/2013 - 06/2012
2	Cytotoxins (Cytolysins)IBA 08/2012 - 10/2010
2	InterleukinsIBA 03/2012 - 03/2010
2	Toll-Like Receptor 4IBA 04/2009 - 10/2008
1	Arachidonic Acid (Vitamin F)IBA 10/2022
1	Coenzyme A Ligases (Acid-Thiol Ligases)IBA 10/2022
1	Poly (ADP-Ribose) Polymerase-1IBA 01/2022
1	Drug CombinationsIBA 01/2022
1	Anesthetics (Anesthetic Agents)IBA 01/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	Pantothenic Acid (Calcium Pantothenate)FDA Link 01/2022

Therapy/Procedure

38	Therapeutics 01/2022 - 07/2008
33	Drug Therapy (Chemotherapy) 01/2022 - 09/2009
15	Immunotherapy 01/2022 - 12/2014
9	Radiotherapy 01/2022 - 10/2008
3	Photochemotherapy (Photodynamic Therapy) 01/2022 - 01/2018
2	Intravenous Injections 01/2021 - 10/2020
2	Adjuvant Chemotherapy 11/2015 - 05/2012